Thermo Fisher Buys LC Consumable Shop La-Pha-Pack
Thermo Fisher Scientific has purchased chromatography consumables products maker La-Pha-Pack for an undisclosed sum, the company said this week.
Thermo Fisher said La-Pha-Pack, based in Langerwehe, Germany, has revenues of around $25 million, but it was not immediately clear in what time period those revenues were generated. The firm sells products such as liquid chromatography filters and vials.
The acquisition will enable Thermo Fisher to offer a broader line of chromatography consumables over a wider area in Europe, and will complement its UK-based Chromacol brand, Thermo Fisher said.
The company will integrate La-Pha-Pack into its lab consumables business in its Laboratory Products and Services Segment.
Oxford Genome, Amgen Produce Cancer Antibodies
Oxford Genome Sciences this week announced it is collaborating with Amgen for the discovery, development, and commercialization of therapeutic antibodies for cancer.
The antibodies will be developed using Amgen’s XenoMouse technology, then raised against druggable targets identified by Oxford Genome through its Anatomy Project database.
The agreement covers up to six oncology programs. Amgen has the right to select up to three programs with Oxford Genome retaining the rights to the rest. After Amgen has produced the initial antibody leads, Oxford Genome will carry out the initial pre-clinical assessment of each antibody program.
Further terms of the deal were not disclosed.
Promega Coming to Sweden
Promega said this week it will open an office in Stockholm next month to offer its products and services directly to the Swedish research community. The company, based in Madison, Wis., previously had a distribution deal with SDS BioSciences in Sweden.
The company has hired Patrick Van de Velde as general manager of the office. In a statement, William Linton, CEO of Promega said that Sweden has the fourth-largest biotech industry in Europe with 48,000 full-time employees in R&D.